If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
400.00    0.00 (0.00%)
Bid:
395.00
Ask:
405.00
Spread: 10.00 (2.532%)
Market Cap: £191.99m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Result of Placing

7 Apr 2017 17:04

RNS Number : 9840B
Tristel PLC
07 April 2017
 

 

Tristel plc

("Tristel" or "the Company")

 

£5.8m placing of 3,329,371 new and existing Ordinary Shares

Exercise of Options

Director Dealing

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, is pleased to announce that in order to satisfy market demand and broaden the institutional shareholder base of the Company, finnCap, as the Company's broker, have conducted a placing of 3,086,871 existing ordinary shares of 1 penny each in the Company and 242,500 new Ordinary Shares (the "Placing Shares" and the "Placing") with new and existing institutional investors.

 

The Placing Shares have been sold on behalf of certain directors of the Company (the "Vendors"). The Placing Shares were sold at a price of 175 pence per share and represent, in aggregate, 7.79 per cent. of the issued share capital of the Company.

 

Included in the shares sold by the Vendors are 242,500 Ordinary Shares sold by Paul Swinney, pursuant to an exercise of options under the Tristel plc Performance Share Plan 2009 ("the 2009 Option Plan").

 

Subsequent to the Placing, the Vendors revised shareholdings are set out below:

 

Vendors

Placing Shares sold

Resultant shareholding

 

Number of Ordinary Shares

% of Issued Share Capital

Number of Ordinary Shares

% of Issued Share Capital

Francisco Soler*

2,500,000

5.85%

8,413,834

19.70%

Paul Swinney**

689,371

1.61%

483,129

1.13%

Paul Barnes

140,000

0.33%

590,180

1.38%

 

*Includes family and related corporate vehicles

 

**following the sale of 242,500 Ordinary Shares pursuant to the exercise of options under the 2009 Option Plan, Paul Swinney now holds 1,156,679 options, representing 2.71% of the issued share capital.

 

Application has been made for the 247,500 new Ordinary Shares to be admitted to trading on AIM ("Admission"), including 5,000 new Ordinary Shares pursuant to the exercise of employee share options. The employee options are not being sold as part of the Placing and dealings in 247,500 new Ordinary Shares are expected to commence on 12 April 2017. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.

The total number of Ordinary Shares in issue following Admission will be 42,718,917. Accordingly, the figure of 42,718,917 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

For further information please contact:

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

Liz Dixon, Finance Director

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07854 391 303

finnCap

Tel: 020 7220 0500

Geoff Nash (Corporate Finance)

Giles Rolls (Corporate Finance)

Alice Lane (Corporate Broking)

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Francisco Soler

2.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary shares of 1p

Identification code

GB00B07RVT99

b)

Nature of the transaction

 

Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

175p

2,500,000

d)

Aggregated information:

· Aggregated volume

· Price

 

Sale of 2,500,000 ordinary shares of 1p pence at £1.75 per ordinary share

e)

Date of the transaction

7 April 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

5.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Barnes

6.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

n/a

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary shares of 1p

Identification code

GB00B07RVT99

b)

Nature of the transaction

 

Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

175p

140,000

d)

Aggregated information:

· Aggregated volume

· Price

 

Sale of 140,000 ordinary shares of 1p pence at £1.75 per ordinary share

e)

Date of the transaction

7 April 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

9.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Swinney

10.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

11.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

n/a

12.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary shares of 1p

Identification code

GB00B07RVT99

b)

Nature of the transaction

 

Exercise of share options and sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

53.75p

242,500

175p

689,371

d)

Aggregated information:

· Aggregated volume

· Price

 

 

Exercise of 242,500 share options

Sale of 689,371 ordinary shares of 1p pence at £1.75 per ordinary share

 

e)

Date of the transaction

7 April 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUGUWUCUPMGQM
Date   Source Headline
17th Jun 20267:00 amRNSAppointment of CEO
16th Jun 202612:00 pmRNSHolding(s) in Company
10th Jun 20267:00 amRNSExercise of Share Options & Total Voting Rights
13th May 202610:10 amRNSExercise of Share Options and Total Voting Rights
5th May 20267:00 amRNSExercise of Share Options and Total Voting Rights
20th Apr 20262:28 pmRNSHolding(s) in Company
20th Apr 20268:20 amRNSHolding(s) in Company
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNS-RConference attendance at ShareSoc Leeds
17th Mar 20265:13 pmRNSHolding(s) in Company
3rd Mar 20264:04 pmRNSPCA Dealing
2nd Mar 20267:00 amRNSHalf-year Financial Report
12th Feb 20267:00 amRNSExercise of Share Options and Total Voting Rights
6th Feb 202611:56 amRNSExercise of Share Options and Total Voting Rights
6th Feb 20267:00 amRNSNotice of Results
22nd Jan 20267:00 amRNSPositive H1 Trading Update & Directorate Change
8th Jan 20263:10 pmRNSExercise of Share Options and Total Voting Rights
12th Dec 202510:37 amRNSDirector/PDMR Shareholding
12th Dec 20259:19 amRNSExercise of Share Options and Total Voting Rights
11th Dec 202511:54 amRNSResult of AGM
11th Dec 20257:00 amRNSAGM Statement
24th Nov 202512:28 pmRNSDirector Option Grant
24th Nov 20257:00 amRNSUpdated US guidelines for high level disinfection
18th Nov 20257:00 amRNSNotice of AGM & Posting of Annual Report &Accounts
12th Nov 202511:33 amRNSHolding(s) in Company
31st Oct 20254:11 pmRNSHolding(s) in Company
31st Oct 20252:12 pmRNSHolding(s) in Company
22nd Oct 20254:56 pmRNSHolding(s) in Company
16th Oct 20254:00 pmRNSExercise of Share Options and Total Voting Rights
13th Oct 202512:00 pmRNSExercise of Share Options and Total Voting Rights
13th Oct 20257:00 amRNSFinal Results
9th Oct 202510:06 amRNSExercise of Share Options and Total Voting Rights
25th Sep 20257:00 amRNSVISICLEAN Product Launch
16th Sep 20257:00 amRNSNotice of Preliminary Results
11th Sep 20257:00 amRNSExercise of Share Options and Total Voting Rights
1st Sep 20257:00 amRNSConfirmation of CFO Appointment
21st Aug 20253:56 pmRNSHolding(s) in Company
18th Aug 202512:15 pmRNSExercise of Share Options and Total Voting Rights
6th Aug 20254:05 pmRNS-RCapital Markets Day video update
29th Jul 20257:00 amRNSTrading update
24th Jul 20257:00 amRNSConfirmation of Investor presentations
17th Jul 20257:00 amRNSAppointment of Chief Financial Officer
4th Jul 20251:02 pmRNSHolding(s) in Company
26th Jun 20257:00 amRNS-RAPIC25 Annual Conference attendance
2nd Jun 20257:00 amRNSInvestor Presentations & Notice of Trading Update
30th May 20257:00 amRNSHolding(s) in Company
28th May 20257:00 amRNS-RConference attendance at Mello2025 Investor event
16th May 20257:00 amRNSExercise of Share Options and Total Voting Rights
15th May 20257:00 amRNSCFO succession planning
12th May 20257:00 amRNSFDA clearance for Tristel OPH

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.